Holding(s) in Company
The Goldman Sachs Group Inc. has notified Oxford Biomedica PLC of a change in its major holdings, with its total voting rights and financial instruments now standing at 1.778248%, down from a previous 5.083440%. This change, effective September 17, 2026, involves a decrease in voting rights attached to shares to 0.000251% and a significant reduction in voting rights through financial instruments to 1.777997%. The company noted that previous reportable positions are now exempt under the market making exemption as they are below the 10% limit.
Select text to share a quote on X · sign in to keep highlights & notes in your OXB notes
Issuer Details
ISIN
GB00BDFBVT43
Issuer Name
OXFORD BIOMEDICA PLC
UK or Non-UK Issuer
UK
Reason for Notification
An acquisition or disposal of voting rights; An acquisition or disposal of financial instruments
Details of person subject to the notification obligation
Name
The Goldman Sachs Group Inc
City of registered office (if applicable)
Wilmington, Delaware
Country of registered office (if applicable)
USA
Details of the shareholder
City of registered office (if applicable)
Country of registered office (if applicable)
Date on which the threshold was crossed or reached
17-Sep-2026
Date on which Issuer notified
21-Sep-2026
- Total positions of person(s) subject to the notification obligation
| % of voting rights attached to shares (total of 8.A) | % of voting rights through financial instruments (total of 8.B 1 + 8.B 2) | Total of both in % (8.A + 8.B) | Total number of voting rights held in issuer | |
|---|---|---|---|---|
| Resulting situation on the date on which threshold was crossed or reached | 0.000251 | 1.777997 | 1.778248 | 2152565 |
| Position of previous notification (if applicable) | 0.001408 | 5.082032 | 5.083440 | |
| 8A. Voting rights attached to shares | ||||
| Class/Type of shares ISIN code(if possible) | Number of direct voting rights (DTR5.1) | Number of indirect voting rights (DTR5.2.1) | % of direct voting rights (DTR5.1) | % of indirect voting rights (DTR5.2.1) |
| GB00BDFBVT43 | 304 | 0.000251 | ||
| Sub Total 8.A | 304 | 0.000251% | ||
| 8B1. Financial Instruments according to (DTR5.3.1R.(1) (a)) | ||||
| Type of financial instrument | Expiration date | Exercise/conversion period | Number of voting rights that may be acquired if the instrument is exercised/converted | % of voting rights |
| Securities Lending | Open | 2152261 | 1.777997 | |
| Sub Total 8.B1 | 2152261 | 1.777997% | ||
- Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))
| Type of financial instrument | Expiration date | Exercise/conversion period | Physical or cash settlement | Number of voting rights | % of voting rights |
Sub Total 8.B2
- Information in relation to the person subject to the notification obligation
| Ultimate controlling person | Name of controlled undertaking | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
| The Goldman Sachs Group, Inc. (Chain 1) | ||||
| The Goldman Sachs Group, Inc. (Chain 1) | GSAM Holdings LLC | |||
| The Goldman Sachs Group, Inc. (Chain 1) | Goldman Sachs Asset Management, L.P. | |||
| The Goldman Sachs Group, Inc. (Chain 2) | ||||
| The Goldman Sachs Group, Inc. (Chain 2) | Goldman Sachs (UK) L.L.C. | |||
| The Goldman Sachs Group, Inc. (Chain 2) | Goldman Sachs Group UK Limited | |||
| The Goldman Sachs Group, Inc. (Chain 2) | Goldman Sachs International | |||
In case of proxy voting
Name of the proxy holder
The number and % of voting rights held
The date until which the voting rights will be held
If date does not apply, explain below
Additional Information
General email contact:
Date of Completion
21-Sep-2026
Place Of Completion
Bengaluru
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.